Stay updated on Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial

Sign up to get notified when there's something new on the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-28T15:55:02.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A sitewide NIH notice was added, announcing updates to terminology around artificial intelligence during a transition period.
    Difference
    1%
    Check dated 2026-10-21T21:47:28.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-14T21:51:37.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-07T22:00:15.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Core identifiers and metadata were removed (drug name Vedolizumab, disease terms, locations, investigators, and related study metadata). This alters how the study is described and discovered on the page by reducing contextual keywords and references.
    Difference
    18%
    Check dated 2026-09-23T21:43:53.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.6 to v3.7.0, indicating a new build or documentation update reflected on the page.
    Difference
    0.1%
    Check dated 2026-09-16T20:14:28.000Z thumbnail image

Stay in the know with updates to Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page.